{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T18:43:03Z","timestamp":1787164983793,"version":"build-2736575974"},"reference-count":24,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100004330","name":"GlaxoSmithKline","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004330","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Green and Sustainable Manufacturing Trust Fund"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Pharmaceutics"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1016\/j.ijpharm.2017.03.021","type":"journal-article","created":{"date-parts":[[2017,3,19]],"date-time":"2017-03-19T20:32:10Z","timestamp":1489955530000},"page":"42-51","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Direct comparison between millifluidic and bulk-mixing platform in the synthesis of amorphous drug-polysaccharide nanoparticle complex"],"prefix":"10.1016","volume":"523","author":[{"given":"Bingxue","family":"Dong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kunn","family":"Hadinoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijpharm.2017.03.021_bib0005","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1002\/smll.201102100","article-title":"Developing a millifluidic platform for the synthesis of ultrasmall nanoclusters: ultrasmall copper nanoclusters as a case study","volume":"8","author":"Biswas","year":"2012","journal-title":"Small"},{"key":"10.1016\/j.ijpharm.2017.03.021_bib0010","doi-asserted-by":"crossref","first-page":"6035","DOI":"10.1039\/c2ce25846c","article-title":"Perphenazine-fumaric acid salts with improved solubility: preparation, physico-chemical characterization and in vitro dissolution","volume":"14","author":"Bruni","year":"2012","journal-title":"CrystEngComm"},{"key":"10.1016\/j.ijpharm.2017.03.021_bib0015","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.ijpharm.2016.07.011","article-title":"Electrospun fibers as potential carrier systems for enhanced drug release of perphenazine","volume":"511","author":"Bruni","year":"2016","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2017.03.021_bib0020","doi-asserted-by":"crossref","first-page":"7007","DOI":"10.1021\/la205131e","article-title":"Size-controlled flow synthesis of gold nanoparticles using a segmented flow microfluidic platform","volume":"28","author":"Cabeza","year":"2012","journal-title":"Langmuir"},{"key":"10.1016\/j.ijpharm.2017.03.021_bib0025","doi-asserted-by":"crossref","DOI":"10.1038\/srep25876","article-title":"Liposome production by microfluidics: potential and limiting factors","volume":"6","author":"Carugo","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ijpharm.2017.03.021_bib0030","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.colsurfb.2011.11.024","article-title":"Green preparation of antibiotic nanoparticle complex as potential anti-biofilm therapeutics via self-assembly amphiphile-polyelectrolyte complexation with dextran sulfate","volume":"92","author":"Cheow","year":"2012","journal-title":"Colloids Surf. B-Biointerfaces"},{"key":"10.1016\/j.ijpharm.2017.03.021_bib0035","doi-asserted-by":"crossref","first-page":"9050","DOI":"10.1021\/acs.macromol.5b02145","article-title":"Surfactant-mediated polyelectrolyte self-assembly in a polyelectrolyte-surfactant complex","volume":"48","author":"Goswami","year":"2015","journal-title":"Macromolecules"},{"key":"10.1016\/j.ijpharm.2017.03.021_bib0040","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1039\/c2nj40763a","article-title":"Silver nanowires and nanoparticles from a millifluidic reactor: application to metal assisted silicon etching","volume":"36","author":"Gottesman","year":"2012","journal-title":"N. J. Chem."},{"key":"10.1016\/j.ijpharm.2017.03.021_bib0045","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1177\/0091270009343694","article-title":"Population pharmacokinetics of perphenazine in schizophrenia patients from CATIE: impact of race and smoking","volume":"50","author":"Jin","year":"2010","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.ijpharm.2017.03.021_bib0050","doi-asserted-by":"crossref","first-page":"601","DOI":"10.3109\/03639040903386690","article-title":"Perphenazine solid dispersions for orally fast-disintegrating tablets: physical stability and formulation","volume":"36","author":"Laitinen","year":"2010","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.ijpharm.2017.03.021_bib0055","doi-asserted-by":"crossref","first-page":"4135","DOI":"10.1021\/nn4005022","article-title":"A simple millifluidic benchtop reactor system for the high-throughput synthesis and functionalization of gold nanoparticles with different sizes and shapes","volume":"7","author":"Lohse","year":"2013","journal-title":"ACS Nano"},{"key":"10.1016\/j.ijpharm.2017.03.021_bib0060","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejpb.2015.07.007","article-title":"Cost-effective alternative to nano-encapsulation: amorphous curcumin-chitosan nanoparticle complex exhibiting high payload and supersaturation generation","volume":"96","author":"Nguyen","year":"2015","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ijpharm.2017.03.021_bib0065","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1098\/rsta.2003.1355","article-title":"Introduction: mixing in microfluidics","volume":"362","author":"Ottino","year":"2004","journal-title":"Philos. Trans. R. Soc. Lond. Ser. A\u2013Math. Phys. Eng. Sci."},{"key":"10.1016\/j.ijpharm.2017.03.021_bib0070","doi-asserted-by":"crossref","first-page":"542","DOI":"10.3109\/02652048.2014.885606","article-title":"A novel approach for antibody nanocarriers development through hydrophobic ion-pairing complexation","volume":"31","author":"Patel","year":"2014","journal-title":"J. Microencapsul."},{"key":"10.1016\/j.ijpharm.2017.03.021_bib0075","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1021\/op8001273","article-title":"Microreactor technology and continuous processes in the fine chemical and pharmaceutical industry: is the revolution underway?","volume":"12","author":"Roberge","year":"2008","journal-title":"Org. Process Res. Dev."},{"key":"10.1016\/j.ijpharm.2017.03.021_bib0080","doi-asserted-by":"crossref","first-page":"4330","DOI":"10.1021\/mp400439q","article-title":"Evolution of supersaturation of amorphous pharmaceuticals: the effect of rate of supersaturation generation","volume":"10","author":"Sun","year":"2013","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ijpharm.2017.03.021_bib0085","first-page":"1","article-title":"Perphenazine versus low-potency first-generation antipsychotic drugs for schizophrenia","volume":"10","author":"Tardy","year":"2014","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.ijpharm.2017.03.021_bib0090","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.ijpharm.2006.08.013","article-title":"Formulation and characterization of amphotericin B-chitosan-dextran sulfate nanoparticles","volume":"329","author":"Tiyaboonchai","year":"2007","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2017.03.021_bib0095","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.ejpb.2016.11.030","article-title":"Millifluidic synthesis of amorphous drug-polysaccharide nanoparticle complex with tunable size intended for supersaturating drug delivery applications","volume":"112","author":"Tran","year":"2017","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ijpharm.2017.03.021_bib0100","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/j.2042-7158.2010.01173.x","article-title":"Fast-dissolving sublingual solid dispersion and cyclodextrin complex increase the absorption of perphenazine in rabbits","volume":"63","author":"Turunen","year":"2011","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.ijpharm.2017.03.021_bib0105","doi-asserted-by":"crossref","first-page":"10807","DOI":"10.1021\/jp0450585","article-title":"Salt effect on the complex formation between polyelectrolyte and oppositely charged surfactant in aqueous solution","volume":"109","author":"Wang","year":"2005","journal-title":"J. Phys. Chem. B"},{"key":"10.1016\/j.ijpharm.2017.03.021_bib0110","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.3109\/10837450.2012.700932","article-title":"Development of orally disintegrating tablets of perphenazine\/hydroxypropyl-beta-cyclodextrin inclusion complex","volume":"18","author":"Wang","year":"2013","journal-title":"Pharm. Dev. Technol."},{"key":"10.1016\/j.ijpharm.2017.03.021_bib0115","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1039\/C4LC00080C","article-title":"A microfluidic tubing method and its application for controlled synthesis of polymeric nanoparticles","volume":"14","author":"Wang","year":"2014","journal-title":"Lab Chip"},{"key":"10.1016\/j.ijpharm.2017.03.021_bib0120","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1021\/acs.molpharmaceut.5b00798","article-title":"Improved release of celecoxib from high drug loading amorphous solid dispersions formulated with polyacrylic acid and cellulose derivatives","volume":"13","author":"Xie","year":"2016","journal-title":"Mol. Pharm."}],"container-title":["International Journal of Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517317301977?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517317301977?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,3]],"date-time":"2018-09-03T06:53:41Z","timestamp":1535957621000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378517317301977"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,5]]}},"alternative-id":["S0378517317301977"],"URL":"https:\/\/doi.org\/10.1016\/j.ijpharm.2017.03.021","relation":{},"ISSN":["0378-5173"],"issn-type":[{"value":"0378-5173","type":"print"}],"subject":[],"published":{"date-parts":[[2017,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Direct comparison between millifluidic and bulk-mixing platform in the synthesis of amorphous drug-polysaccharide nanoparticle complex","name":"articletitle","label":"Article Title"},{"value":"International Journal of Pharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijpharm.2017.03.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}